1. Arigoni, R., Chiste, R., Makovec, R., Setnikar, I., Benfenati, E., and Fanelli, R., Identification of metabolites of tiropramide in human urine.Biomed. Environ. Mass Spectrom., 15(4), 205–209 (1988).
2. Arigoni, R., Chiste, R., Drovanti, A., Makovec, R., Senin, P., and Setnikar, I., Pharmacokinetics of tiropramide after single doses in man.Arzneim.-Forsh./Drug Res., 36(4), 738–744 (1986)
3. Setnikar, I., Cereda, R., Pacini, M. A., Revel, L., and Makovec, R., Pharmacological characterization of the smooth muscle antispasmodic agent tiropramide.Arzneim.-Forsh./Drug Res., 39(9), 1114–1119 (1989a).
4. Setnikar, I., Cereda, R., Pacini, M. A., Revel, L., and Makovec, R., Antispasmodic activity of tiropramide.Arzneim.-Forsh. Drug Res., 39(9), 1109–1114 (1989b).
5. Setnikar, I., Makovec, R., Chiste, R., Giachetti, C., and Zanolo, G., Distribution of tiropramide and metabolites after single intravenous or peroral administration of14C-tiropramide to the rat.Arzneim.-Forsh./Drug Res., 39(5), 579–586 (1989c).